Consistent with our findings, multiple studies have identified downregulation of some of the apoptotic genes discovered in this study to play major roles in attenuating GBM apoptosis, especially for BBC3, DCC, BEX2, CASP1, IL1B, and SFRP2 [51–56]. This evidence concerns the gene DCC and glioblastoma.